Indications and uses
Uses : Symptomatic treatment of athletes foot ( tinea pedis ).
Uses : Symptomatic treatment of athletes foot ( tinea pedis ).
Directions: Thoroughly wash and dry affected area. Apply a few drops of product 2-3 times per day to the affected area for 4-7 days or until infection has subsided. To speed healing, we recommend Naturasil Sulfur-Lavender Multi-Purpose Medicated soap. Some individuals may be sensitive to essential oils. Skin test for tolerability. If irritation or reaction occurs, discontinue use.
Drug Facts
Active Ingredients:
Sulfur 6X HPUS
The letters HPUS indicate the component(s) in this product is (are) officially monographed in the Homeopathic Pharmocopeia of the United States.
Uses: Symptomatic treatment of athletes foot (tinea pedis).
Warnings: For external use only.
Ask a doctor before use if pregnant or nursing.
Avoid using near eyes, mouth or mucous membranes.
Keep out of reach of children.
Do not use if tamper evident seal is broken.
In case of ingestion call Poison Control Center hotline immediately at 1-800-222-1222.
Directions:Thoroughly wash and dry affected area. Apply a few drops of product 2-3 times per day to the affected area for 4-7 days or until infection has subsided. To speed healing, we recommend Naturasil Sulfur-Lavender Multi-Purpose Medicated soap. Some individuals may be sensitive to essential oils. Skin test for tolerability. If irritation or reaction occurs, discontinue use.
Inactive Ingredients: Cymbopogon Citratus Leaf Oil, Eucalyptus Leaf Oil, Jojoba Seed Oil, Lavender Oil, Melaleuca Alternifolia Leaf Oil, Patchouli Leaf Oil.
Questions? Comments?
www.naturasil.com 866.371.2499 Mfd. by:
Nature's Innovation, Inc. 2723 Brickton North Dr., Buford, GA 30518
Not tested on animals.
Purpose
Fungus Growth Relief
100% Natural Plant Extracts
Naturasil
ml (fl.oz.)
Topical Liquid
Homeopathic Medicine
Athletes Foot
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SULFUR | ACTIVE INGREDIENT | 70FD1KFU70 | 1 | |
| SULFUR | ACTIVE MOIETY | 70FD1KFU70 | 1 | |
| EUCALYPTUS OIL | INACTIVE INGREDIENT | 2R04ONI662 | 1 | |
| JOJOBA OIL | INACTIVE INGREDIENT | 724GKU717M | 1 | |
| LAVENDER OIL | INACTIVE INGREDIENT | ZBP1YXW0H8 | 1 | |
| PATCHOULI OIL | INACTIVE INGREDIENT | F3IN55X5PO | 1 | |
| TEA TREE OIL | INACTIVE INGREDIENT | VIF565UC2G | 1 | |
| WEST INDIAN LEMONGRASS OIL | INACTIVE INGREDIENT | 5BIA40E9ED | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10893-260 | 10893-260-15, 10893-260-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SULFUR | 70FD1KFU70 | ACTIB |
| WEST INDIAN LEMONGRASS OIL | 5BIA40E9ED | IACT |
| EUCALYPTUS OIL | 2R04ONI662 | IACT |
| JOJOBA OIL | 724GKU717M | IACT |
| LAVENDER OIL | ZBP1YXW0H8 | IACT |
| TEA TREE OIL | VIF565UC2G | IACT |
| PATCHOULI OIL | F3IN55X5PO | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| EUCALYPTUS OIL | EUCALYPTUS OIL | 2R04ONI662 | SYRUP / ORAL | NA | ||
| LAVENDER OIL | LAVENDER OIL | ZBP1YXW0H8 | GEL / TOPICAL | 0.1 %w/w | ||
| LAVENDER OIL | LAVENDER OIL | ZBP1YXW0H8 | INHALANT / NASAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| db17acae-592a-44a7-863e-2ff341ec724b | cacb2f70-0e5b-427a-bacb-cd40c9e7ffa2 | 2024-07-26 | Warnings | cacb2f70-0e5b-427a-bacb-cd40c9e7ffa2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.